Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Keith, Bruce D ^a  

^a Sault Area Hospitals   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; CORTISONE; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; DROSTANOLONE PROPIONATE; FLUOROMETHOLONE; FLUOROURACIL; FLUTAMIDE; FUROSEMIDE; GLUCOCORTICOID; HYDROCORTISONE; KETOCONAZOLE; LIAROZOLE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; METHOTREXATE; METHYLPREDNISOLONE; MITOMYCIN C; MITOXANTRONE; PHENYLALANINE; PLACEBO; PREDNISOLONE; PREDNISONE; TAMOXIFEN; UNINDEXED DRUG; VINCRISTINE;

ADRENALECTOMY; ADVANCED CANCER; BLADDER CANCER; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER SURVIVAL; CARCINOID; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; COCHRANE LIBRARY; COLON CANCER; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBASE; ESOPHAGUS CANCER; EVENING DOSAGE; GALLBLADDER CANCER; GASTROINTESTINAL DISEASE; GLIOMA; HEAD AND NECK CANCER; HEART CARCINOMA; HUMAN; HYPERCALCEMIA; KIDNEY CANCER; KIDNEY CARCINOMA; LEUKOCYTE COUNT; LEUKOPENIA; LIVER CANCER; LIVER CARCINOMA; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG CARCINOMA; LUNG METASTASIS; LUNG SARCOMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; MELANOMA; MONOTHERAPY; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NAUSEA AND VOMITING; NEUTROPENIA; ORCHIECTOMY; OVARY CANCER; PANCREAS CANCER; PLEURA TUMOR; PREMEDICATION; PROGNOSIS; PROSTATE CANCER; RECTUM CANCER; REVIEW; SARCOMA; SIDE EFFECT; SOFT TISSUE CANCER; SOLID TUMOR; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THYMOMA; THYROID CANCER; TUMOR LYSIS SYNDROME; UTERINE CERVIX CANCER; UTERUS CANCER; FEMALE; MALE; META ANALYSIS; NEOPLASM;

CLINICAL TRIALS AS TOPIC; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; NEOPLASMS;

EID: 42649107218     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-84     Document Type: Review

References (97)

1. Rutz HP Effects of corticosteroid use on treatment of solid tumours Lancet 2002 360: 9349-1969 1970 10.1016/S0140-6736(02)11922-2 12493280
2. Herr I Pfitzenmaier J Glucocorticoid use in prostate cancer and other solid tumours: Implications for effectiveness of cytotoxic treatment and metastases Lancet Oncol 2006 7(5):425- 430 10.1016/S1470-2045(06)70694-5 16648047
3. Jadad AR Moore RA Carroll D Jenkinson C Reynolds DJ Gavaghan DJ McQuay HJ Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996 17(1):1-12 10.1016/ 0197-2456(95)00134-4 8721797
4. Undertaking Systematic Reviews of Research on Effectiveness, CRD's Guidance for Those Carrying Out or Commissioning Reviews CRD Report Number 4 Centre for Reviews and Dissemination, University of York, York, UK 2
5. Colsky J A comparative study of 9alpha-bromo-11beta-keto-progesterone and prednisolone in the treatment of advanced carcinoma of the female breast Cancer 1963 16 502 505 10.1002/ 1097-0142(196304)16:4<502::AID-CNCR2820160410>3.0.CO;2-M 14022451
6. Fentiman IS Howell A Hamed H Lee SM Ranson M Wall J Chaudary MA Ash CM Gregory WM Sellwood RA A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer Br J Cancer 1994 70(4):729-731 7917929
7. Ingle JN Mailliard JA Schaid DJ Krook JE Gesme DH Jr Windschitl HE Pfeifle DM Etzell PS Gerstner JG Long HJ A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic Cancer 1991 68(1):34-39 10.1002/ 1097-0142(19910701)68:1<34::AID-CNCR2820680107>3.0.CO;2-Q 2049750
8. Patel SR Kvols LK Hahn RG Windschitl H Levitt R Therneau T A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate Cancer 1990 66(4):655-658 10.1002/ 1097-0142(19900815)66:4<655::AID-CNCR2820660409>3.0.CO;2-P 2201425
9. DiMartino L Demontis B Mitchell IP Hayward SW Deshpande N A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: A preliminary report Anticancer Res 1991 11(2):869-872 2064345
10. Macbeth F Gregor A Cottier B A randomised study of megestrol acetate (MA) and prednisolone (P) for anorexia and weight loss in patients with lung cancer Lung Cancer 1994 11(Supplement 1):334
11. Kemeny N Seiter K Niedzwiecki D Chapman D Sigurdson E Cohen A Botet J Oderman P Murray P A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer Cancer 1992 69(2):327-334 10.1002/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U 1303612
12. Tormey DC Gray R Gilchrist K Grage T Carbone PP Wolter J Woll JE Cummings FJ Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial Cancer 1990 65(2):200-206 10.1002/1097-0142(19900115)65:2<200::AID-CNCR2820650203>3.0.CO;2-Q 2403834
13. Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish trial. Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London Lancet 1993 341(8856):1293-1298 8098446
14. Lundholm K Gelin J Hyltander A Lonnroth C Sandstrom R Svaninger G Korner U Gulich M Karrefors I Norli B Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors Cancer Res 1994 54(21):5602-5606 7923204
15. Goldenberg IS Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group Cancer 1969 23(1):109-112 10.1002/ 1097-0142(196901)23:1<109::AID-CNCR2820230112>3.0.CO;2-1 4884063
16. Ramirez G Klotz J Strawitz JG Wilson WL Cornell GN Madden RE Minton JP Combination chemotherapy in breast cancer: A randomized study of 4 versus 5 drugs Oncology 1975 32 (3-4):101-108 1221326
17. Brambilla C De Lena M Bonadonna G Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma Cancer Chemother Rep 1974 58(2):251-253 4598244
18. Gaertner RA Lewison EF Finney GG Jr Montague AC Combined hormone therapy in advanced breast cancer. Triple-blind study of 68 patients treated with dromostanolone and fluorometholone Johns Hopkins Med J 1968 123(3):138-141 4876823
19. Dao TL Tan E Brooks V A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma Cancer 1961 14:1259-1265 10.1002/1097-0142(196111/ 12)14:6<1259::AID-CNCR2820140616>3.0.CO;2-4 13883499
20. Reitemeier RJ Moertel CG Hahn RG Comparative evaluation of palliation with fluorometholone (NSC-33001), 5-fluorouracil (NSC-19893), and combined fluorometholone and 5-fluorouracil in advanced gastrointestinal cancer Cancer Chemother Rep 1967 51(2):77-80 4167184
21. Tormey DC Gelman R Band PR Sears M Rosenthal SN DeWys W Perlia C Rice MA Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial Cancer 1982 50(7):1235-1244 10.1002/1097-0142(19821001)50:7<1235::AID-CNCR2820500703>3.0.CO;2-L 7049347
22. Talley RW Brennan MJ Vaitkevicius VK Sandiego EL Reed ML Leighton GA Comparison of 6-Alpha-Methyl-9-Alpha-Fluoro-17-Acetoxy-21-Deoxyprednisolone with Fluoxymesterone and Methylprednisolone in Treatment of Metastatic Breast Cancer Cancer 1964 17:1063-1066 10.1002/ 1097-0142(196408)17:8<1063::AID-CNCR2820170812>3.0.CO;2-T 14202593
23. Green SB Byar DP Walker MD Pistenmaa DA Alexander E Jr Batzdorf U Brooks WH Hunt WE Mealey J Jr Odom GL Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma Cancer Treat Rep 1983 67(2):121-132 6337710
24. Stewart JF Rubens RD King RJ Minton MJ Steiner R Tong D Winter PJ Knight RK Hayward JL Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer Eur J Cancer Clin Oncol 1982 18(12):1307-1314 10.1016/0277-5379(82)90134-1 6891929
25. Rossi A Brambilla C Bonadonna G Controlled study with 1-phenylalanine mustard (l-PAM) and 5-fluorouracil (5-FU) plus or minus prednisone in advanced breast cancer Tumori 1976 62(2):193-196 1006810
26. Moertel CG Schutt AJ Reitemeier RJ Hahn RG Corticosteroid therapy of preterminal gastrointestinal cancer Cancer 1974 33(6):1607-1609 10.1002/ 1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V 4135151
27. Horton J Olson KB Hosley HF Corticosteroids and fluorouracil toxicity Arch Intern Med 1966 117(6):775-777 10.1001/archinte.117.6.775 5327216
28. Piccart MJ Klijn J Paridaens R Nooij M Mauriac L Coleman R Bontenbal M Awada A Selleslags J Van Vreckem A Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: Final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer J Clin Oncol 1997 15(9):3149-3155 9294478
29. Sorensen S Helweg-Larsen S Mouridsen H Hansen HH Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: A randomised trial Eur J Cancer 1994 30A(1):22-27 10.1016/S0959-8049(05)80011-5 8142159
30. Della Cuna GR Pellegrini A Piazzi M Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group Eur J Cancer Clin Oncol 1989 25(12):1817-1821 10.1016/0277-5379(89)90353-2 2698804
31. Gercovich F Negro A Requejo H Morgenfeld E Rivarola E Pasccon G Botto G Marantz A Tessler J Elli A 5Fluorouracil, cyclophosphamide and mitoxantrone (fucimix) vs fucimix-prednisone (pdn) for advanced breast cancer (abc). A prospective and randomized trial. Preliminar report Proceedings of AACR 1989 30: 1014
32. Fossa SD Slee PH Brausi M Horenblas S Hall RR Hetherington JW Aaronson N de Prijck L Collette L Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European organization for research and treatment of cancer genitourinary group J Clin Oncol 2001 19(1):62-71 11134196
33. Fossa SD Jahnsen JU Karlsen S Ogreid P Haveland H Trovag A High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study Eur Urol 1985 11(1):11-16 3157571
34. Thatcher N Wagstaff J Wilkinson P Palmer M Crowther D Intermittent high-dose cyclophosphamide with and without prednisolone: A study of the relationships between toxicity, response and survival in metastatic lung cancer Cancer 1982 50(6):1051-1056 10.1002/ 1097-0142(19820915)50:6<1051::AID-CNCR2820500605>3.0.CO;2-X 7049346
35. Datta SN Thomas K Matthews PN Is prednisolone as good as flutamide in hormone refractory metastatic carcinoma of the prostate? J Urol 1997 158(1):175-177 10.1097/00005392-199707000-00056 9186348
36. Sabbatini P Larson SM Kremer A Zhang ZF Sun M Yeung H Imbriaco M Horak I Conolly M Ding C Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer J Clin Oncol 1999 17(3):948-957 10071289
37. Cocconi G Bisagni G Ceci G Bacchi M Boni C Brugia M Carpi A Di Costanzo F Franciosi V Gori S Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: A prospective randomized trial of the Italian Oncology Group for Clinical Research J Clin Oncol 1992 10(6):984-989 1588379
38. Jakobsen A Frederiksen PL Moller KA Andersen AP Brincker H Dombernowsky P Hansen PV Hesselius I Kjaer M Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial Eur J Cancer Clin Oncol 1986 22(9):1067-1072 10.1016/0277-5379(86)90007-6 2946583
39. Popiela T Lucchi R Giongo F Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group Eur J Cancer Clin Oncol 1989 25(12):1823-1829 10.1016/0277-5379(89)90354-4 2483687
40. Tashiro H Nomura Y Mitomycin C, methotrexate, and vincristine with medroxyprogesterone acetate or prednisolone for doxorubicin resistant advanced breast cancer - a randomized control study Anticancer Res 1995 15(5B):2229-2237 8572630
41. Wolf J Spear P Yesner R Patno ME Nitrogen mustard and the steroid hormones in the treatment of inoperable bronchogenic carcinoma Am J Med 1960 29:1008-1016 10.1016/0002-9343(60)90081-4 13786281
42. Wolf J Spear P Yesner R Patno ME The Sex Hormones and Cortisone in the Treatment of Inoperable Bronchogenic Carcinoma Biological activities of steroids in relation to cancer New York: Academic Press Pincus G, Vollmer EP 1960 413-426
43. Sander S Nissen-Meyer R Aakvaag A Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study Scand J Urol Nephrol 1982 16(3):193-197 6219455
44. Meakin JW Hayward JL Panzarella T Allt WE Beale FA Bulbrook RD Bush RS Clark RM Fitzpatrick PJ Hawkins NV Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast Breast Cancer Res Treat 1996 37 1:11-19 10.1007/BF01806627 8750523
45. Rinehart JJ Davidson S Deshazo M Cloud M Busby L Robert F Phase l Trial of Dexamethasone (Dex), Carboplatin (C) and Gemcitabine (G) in Untreated Non-Small Cell Lung Cancer (NSCLC) Proceedings of ASCO 2005 23:16S-7111
46. Rubens RD Tinson CL Coleman RE Knight RK Tong D Winter PJ North WR Prednisolone improves the response to primary endocrine treatment for advanced breast cancer Br J Cancer 1988 58(5):626-630 3219274
47. Kristensen B Ejlertsen B Holmegaard SN Krarup-Hansen A Transbol I Mouridsen H Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: A randomized study J Intern Med 1992 232 3 237 245 1402620
48. Tormey D Gelman R Falkson G Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial Am J Clin Oncol 1983 6(1):1-18 6340458
49. Loprinzi CL Kugler JW Sloan JA Mailliard JA Krook JE Wilwerding MB Rowland KM Jr Camoriano JK Novotny PJ Christensen BJ Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia J Clin Oncol 1999 17(10):3299-3306 10506633
50. Tombal B Tourani J-M Kizazi K Culine S Lotz J-P Kaci M Coppola F Kahatt C Weems G Cvitkovic E Randomized phase ll trial of irofulven (IROF) with or without prednisone in hormone -refractory prostate cancer (HRPC) patients (pts) Proceedings of ASCO 2003 22:1636
51. Sato N Koeda K Ikeda K Kimura Y Aoki K Iwaya T Akiyama Y Ishida K Saito K Endo S Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer Ann Surg 2002 236(2):184-190 1422564 12170023 10.1097/00000658-200208000-00006
52. Bernhardt B Nemunaitis JJ Ebrahimi B Cervera A Birch R Richards DA Smith GB Allerton JP Henderson IC The addition of prednisone (Pr) to the combination of docetaxel (T) and perifosine (P) decreases the severity of gastrointestinal (GI) toxicity Proceedings of ASCO 2006 24:18S-13142
53. Marini G Murray S Goldhirsch A Gelber RD Castiglione-Gertsch M Price KN Tattersall MH Rudenstam CM Collins J Lindtner J The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group Ann Oncol 1996 7(3):245-250 8740787
54. Oncologic Drugs Advisory Committee, Fifty-Third Meeting, Center for Drug Evaluation and Research, Food and Drug Administration Bethesda, MD 1997 1-192 http://www.fda.gov/ohrms/dockets/ac/97/transcpt/3289t2.pdf
55. Mercer PM Ebbs SR Fraser SC Coltart RS Bates T Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer Eur J Surg Oncol 1993 19(3):254-258 8314383
56. Wander HE Kleeberg UR Essers U Blossey HC Nagel GA Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study Onkologie 1987 10(5):321-323 2960938
57. Graham PH Capp A Delaney G Goozee G Hickey B Turner S Browne L Milross C Wirth A A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study Clin Oncol (R Coll Radiol) 2006 18(1):70-76 16477923
58. Yano M Taniguchi M Tsujinaka T Fujiwara Y Yasuda T Shiozaki H Monden M Is preoperative methylprednisolone beneficial for patients undergoing esophagectomy? Hepatogastroenterology 2005 52(62):481-485 15816462
59. Williams G Asopa R Abel PD Smith C Pituitary adrenal and gonadal endocrine suppression for the primary treatment of prostate cancer Br J Urol 1990 65(5):504-508 2141289
60. Tyrrell C Liazal Versus Cyproterone Acetate (CPA) or Prednisone in Hormone-Resistant Prostate Cancer: Results of Two Clinical Trials Annals of Oncology 1996 7(Supplement 5):57
61. Mercadante SL Berchovich M Casuccio A Fulfaro F Mangione S A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients Am J Hosp Palliat Care 2007 24(1):13-19 10.1177/ 1049909106295431 17347500
62. Feuer DJ Broadley KE Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee Ann Oncol 1999 10(9):1035-1041 10.1023/ A:1008361102808 10572600
63. Mass RE Clinical Evaluation Of Oxylone (NSC-33001) Cancer Chemother Rep 1964 38:49-60 14167468
64. Moertel CG Reitemeier RJ Hahn RG Blackburn CM Fluorometholone (NSC-33001) As A Palliative In Advanced Gastrointestinal Carcinoma Cancer Chemother Rep 1964 43:25-27 14250648
65. Johnson R Bisel H Andrews N Wilson W Rochlin D Segaloff A Krementz E Aust J Ansfield F Phase l Clinical Study of 6α-Methylpregn-4-ene-3,11,20-trione (NSC-17256) Cancer Chemother Rep 1966 50(9):671-673
66. Ramirez G Weiss AJ Rochlin DB Bisel HF Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256) Cancer Chemother Rep 1971 55(3):265-268 5115847
67. Bruera E Roca E Cedaro L Carraro S Chacon R Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study Cancer Treat Rep 1985 69(7-8):751-754 2410117
68. Postlethwait RW Moseley V McKee KT Murdoch JH Jr McCord WM ACTH and cortisone in advanced carcinoma of the digestive tract Cancer 1951 4(5):984-987 10.1002/ 1097-0142(195109)4:5<984::AID-CNCR2820040512>3.0.CO;2-B 14879363
69. De Camp G Corticosteroid therapy in bronchial carcinoma and other malignant tumors in the thorax Munch Med Wochenschr 1961 103:2026-2030 13875979
70. Plengvanit U Viranuvatti V Treatment Of Primary Carcinoma Of The Liver With Nitrogen Mustard And Prednisolone: Report Of 51 Cases Am J Gastroenterol 1964 42:521-528 14224764
71. Rinehart JJ Randomized Phase ll Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer. ClinicalTrials.gov http://clinicaltrials.gov/show/NCT00176293
72. Mouridsen H Phase ll Randomized Second-Line Endocrine Therapy with AG/HC vs AG vs Low-Dose AG vs Low-Dose AG/HC in Patients with Advanced Breast Cancer EORTC-10861
73. CellGenesys Docetaxel in Combination with GVAX Vaccine Versus Docetaxel and Prednisone in Prostate Cancer Patients. ClinicalTrials.gov http://clinicaltrials.gov/show/NCT00133224
74. Habib GS Saliba WR Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: A case report and review of the literature Am J Med Sci 2002 323(3):155-157 10.1097/00000441-200203000-00007 11908861
75. Chaudhuri PK Das Gupta TK Beattie CW Walker MJ Glucocorticoid-induced exacerbation of metastatic human melanoma J Surg Oncol 1982 20(1):49-52 10.1002/jso.2930200112 7078185
76. Varella AD Bandiera DC de Amorim AR Sr Calvis LA Santos IO Escaleira N Gentil F Treatment of disseminated malignant melanoma with high-dose oral BCG Cancer 1981 48(6):1353-1362 10.1002/ 1097-0142(19810915)48:6<1353::AID-CNCR2820480617>3.0.CO;2-N 7023654
77. Hayashi R Hanyu N Moriyama S Efficacy of steroid therapy on liver metastasis of thymic carcinoid Intern Med 1994 33(1):45-47 10.2169/ internalmedicine.33.45 8180443
78. Omland H Fossa SD Spontaneous regression of cerebral and pulmonary metastases in renal cell carcinoma Scand J Urol Nephrol 1989 23(2):159-160 2756362
79. Tanaka M Fukuda H Higashi Y A case of complete regression of metastatic renal cell carcinoma following corticosteroid treatment Hinyokika Kiyo 2003 49(4):225-228 12784718
80. Farber S Downing V Schwachman H Toch R Appleton R Heald F King JP Feriozi D The Action of ACTH and Cortisone on Children with Disseminated Cancer Second Clinical ACTH Conference The Blakiston Company Mote JR 1951 226-234
81. Jadresic A Pabst I Lazo M Do corticoids favour dissemination of breast cancer? Lancet 1963 2:306-307 10.1016/S0140-6736(63)90215-0 13964420
82. Dao T Moore GE Clinical observations of conditions which apparently enhance malignant cell survival Surg Gynecol Obstet 1961 112:191-195 13719700
83. Pelner L Host-tumor antagonism. XII. Possible effect of the cortisone drugs on the development of metastases in patients with carcinoma J Am Geriatr Soc 1959 7(5):428-439 13653942
84. Tomiak EM Evans WK The role of chemotherapy in invasive thymoma: A review of the literature and considerations for future clinical trials Crit Rev Oncol Hematol 1993 15(2):113-124 10.1016/1040-8428(93)90051-5 8117414
85. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Ludwig Breast Cancer Study Group Cancer Res 1985 45(9):4454-4459 2862995
86. Kemeny N Conti JA Cohen A Campana P Huang Y Shi WJ Botet J Pulliam S Bertino JR Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma J Clin Oncol 1994 12(11):2288-2295 7964942
87. Arisawa Y Sutanto-Ward E Fortunato L Sigurdson ER Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: A regional antiangiogenic therapy Ann Surg Oncol 1995 2(2):114-120 10.1007/ BF02303625 7537164
88. Al-Habet SM Rogers HJ Methylprednisolone pharmacokinetics after intravenous and oral administration Br J Clin Pharmacol 1989 27(3):285-290 1379824 2655680
89. Leggas M Kuo K Cloud G Li M Wang H Zhang R Robert F Rinehart JJ Effects of Dexamethasone (Dex) Pretreatment on Toxicity and Efficacy of Carboplatin and Gemcitabine (Carb/Gem) in Patients with Non-Small Cell Lung Cancer (NSCLC) Proceedings of ASCO 2007 25:18S-18124
90. Plowman PN Glucocorticoids and prostate cancer in castrate men J Clin Oncol 1999 17 12 3856 3860 10577863
91. Minton MJ Knight RK Rubens RD Hayward JL Corticosteroids for elderly patients with breast cancer Cancer 1981 48(4):883-887 10.1002/ 1097-0142(19810815)48:4<883::AID-CNCR2820480404>3.0.CO;2-V 7272933
92. Fossati R Confalonieri C Torri V Ghislandi E Penna A Pistotti V Tinazzi A Liberati A Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women J Clin Oncol 1998 16(10):3439-3460 9779724
93. Axelrod L Corticosteroid Therapy Principles and Practice of Endocrinology Philadelphia: Lippincott Williams and Wilkins Becker KL 3 2001 745 755
94. Rinehart J Keville L Neidhart J Wong L DiNunno L Kinney P Aberle M Tadlock L Cloud G Hematopoietic protection by dexamethasone or granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients treated with carboplatin and ifosfamide Am J Clin Oncol 2003 26 (5):448-458 10.1097/01.coc.0000027268.23258.7D 14528069
95. Murray N Osoba D Shah A Page R Karsai H Little C Brief intensive chemotherapy for metastatic non-small-cell lung cancer: A phase II study of the weekly CODE regimen J Natl Cancer Inst 1991 83(3):190-194 10.1093/ jnci/83.3.190 1846431
96. Valabrega G Montemurro F Aglietta M Trastuzumab: Mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer Ann Oncol 2007 17229773
97. Nair MP Schwartz SA Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes J Immunol 1984 132(6):2876-2882 6202765